国产成人三级网址在线看_日韩高清在线毛片_精品国内自产拍在线观看尤物_欧美精品 亚洲日韩_成人黄色影片在线看_国产一区二区播放_国产午夜理论最新电影_日本伊人久久综合_亚洲国产网站视频在线播放_日韩人妻系列无码专区

趨化因子(C-X-C基序)配體3(CXCL3)多克隆抗體

Polyclonal Antibody to Chemokine (C-X-C Motif) Ligand 3 (CXCL3)

GROg; SCYB3; GRO3; GRO-G; MIP2-B; MIP2b; CINC2b; CINC2b; Growth Regulated Oncogene Gamma; Macrophage inflammatory protein 2-beta

  • 趨化因子(C-X-C基序)配體3(CXCL3)多克隆抗體 產(chǎn)品包裝(模擬)
  • 趨化因子(C-X-C基序)配體3(CXCL3)多克隆抗體 產(chǎn)品包裝(模擬)
  • PAB604Eq01.jpg Figure. Western Blot; Sample: Recombinant GROg, Equine.
  • Certificate 通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

特異性

該抗體是針對(duì)CXCL3的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別CXCL3。

用法

Western blotting: 0.5-2μg/mL
Immunohistochemistry: 5-20μg/mL
Immunocytochemistry: 5-20μg/mL
Optimal working dilutions must be determined by end user.

儲(chǔ)存

經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。

贈(zèng)品

相關(guān)產(chǎn)品

編號(hào) 適用物種:Equus caballus; Equine (Horse,馬) 應(yīng)用(僅供研究使用,不用于臨床診斷!)
RPB604Eq01 趨化因子(C-X-C基序)配體3(CXCL3)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAB604Eq01 趨化因子(C-X-C基序)配體3(CXCL3)多克隆抗體 WB; IHC; ICC; IP.

參考文獻(xiàn)

雜志 參考文獻(xiàn)
PLoS One. Inconformity of CXCL3 Plasma Level and Placenta Expression in Preeclampsia and Its Effect on Trophoblast Viability and Invasion [Pubmed:25485631]
Scientific Reports Epidermal CD147 expression plays a key role in IL-22-induced psoriatic dermatitis. [pubmed:28272440]
Medicine (Baltimore) Rapid detection of urinary soluble intercellular adhesion molecule-1 for determination of lupus nephritis activity [Pubmed:29953010]
Anticancer Research The Clinicopathological Significance of the CXCR2 Ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in Gastric Cancer [Pubmed: 31810929]
SCIENCE OF THE TOTAL ENVIRONMENT Assessment of acute toxicological effects of molybdenum (IV) disulfide nano-and microparticles after single intratracheal administration in rats [Pubmed: 32629262]
留言咨詢